Journal for ImmunoTherapy of Cancer (Apr 2022)

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

  • Xiaoyu Zhang,
  • Anthony M Joshua,
  • Sanjeev Kaul,
  • Scott Antonia,
  • Robert L Ferris,
  • Roger B Cohen,
  • Ezio Bonvini,
  • Jan Baughman,
  • Victoria Atkinson,
  • Charu Aggarwal,
  • Nicholas Vogelzang,
  • Osama Rahma,
  • Mahesh Seetharam,
  • Yanyan Lou,
  • Anthony Tolcher,
  • Fernanda I Arnaldez,
  • Amy Prawira,
  • Ralph Hauke,
  • Vinod Ganju,
  • Andrew Weickhardt,
  • Dan P Zandberg,
  • Arash Rezazadeh Kalebasty,
  • Alex A Adjei,
  • Ariel Birnbaum,
  • Rosetta Cavallo,
  • Linda Peng,
  • Paul A Moore,
  • Stacie M Goldberg,
  • Nehal J Lakhani

DOI
https://doi.org/10.1136/jitc-2021-004424
Journal volume & issue
Vol. 10, no. 4

Abstract

Read online

No abstracts available.